Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures.
<h4>Background and aims</h4>The present study aimed to report our real-life experience of the TPO receptor agonist lusutrombopag for cirrhotic patients with low platelet counts.<h4>Methods</h4>We studied platelet counts in 1,760 cirrhotic patients undergoing invasive procedur...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0211122 |